Cutler Group LP Rapt Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Jan 18, 2022	SELL	$29.5 - $39.5 $227,150 - $304,150	-7,700 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$29.86 - $39.47 $1.22 Million - $1.61 Million	-40,800 Reduced 84.12%	7,700 $25,000
Q2 2021 Jul 19, 2021	BUY	$17.99 - $40.02 $829,338 - $1.84 Million	46,100 Added 1920.83%	48,500 $167,000
Q1 2021 Apr 26, 2021	BUY	$16.0 - $24.46 $20,800 - $31,798	1,300 Added 118.18%	2,400 $1,000
Q4 2020 Jan 21, 2021	BUY	$15.89 - $40.87 $17,479 - $44,957	1,100 New	1,100 $2,000

103

49.4M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $33.8M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.